Microbiome Targets

Certain microbiome target markets offer immediate revenue-generating business opportunities such vaginal and lactal-duct microbiome banking & transplants from mother to child in the case of C-section-born babies, babies of non-nursing mothers, and children under 5 years of age receiving broad-spectrum antibiotics

OmniBiome’s main focus will be on developing Dx / Rx products & services for pregnancy-associated conditions or diseases where there is a documented or substantive putative link with microbiome dysbiosis and resulting inflammatory cascades

In parallel the Company will look to create alliances and/or out license it’s Medical Device / Drug Device Combinations patent portfolio.

The Company also plans to in-license microbiome- and pregnancy-related Rx & Dx innovations from universities and research institutes – several have already been identified.